Nyxoah launches Genio bilateral neurostimulation system in Netherlands
Nyxoah (NASDAQ:NYXH) announced the successful commercial launch of its Genio bilateral neurostimulation system in the Netherlands on Dec. 17, 2025.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Nyxoah (NASDAQ:NYXH) announced the successful commercial launch of its Genio bilateral neurostimulation system in the Netherlands on Dec. 17, 2025.
INNOVATE Corp. (NYSE:VATE) said MediBeacon, in which it holds a 44.7% equity stake, has received U.S. Food and Drug Administration approval for its next-generation MediBeacon TGFR System, introducing a reusable sensor intended to broaden access to point-of-care kidney function assessment.
Scorpio Tankers (NYSE:STNG) agreed to sell two of its 2016-built LR2 product tankers for a combined $104.6 million, while simultaneously expanding its fleet with the purchase of two scrubber-fitted newbuildings scheduled to arrive in 2027.
Cardone Ventures, the investment firm led by billionaire Grant Cardone and business partners Brandon and Natalie Dawson, has made an unsolicited, non-binding proposal to acquire PetMed Express (NASDAQ:PETS) for $4.25 per share in cash, implying an equity value of around $89 million.
Rezolve Ai (NASDAQ:RZLV) expects to exceed $17 million in revenue for December 2025, with annual recurring revenue (ARR) set to surpass $200 million by year-end.
HEICO Corporation (NYSE:HEI) announced that its Flight Support Group subsidiary, Wencor, has entered into an agreement to acquire EthosEnergy Accessories and Components, a leading provider of repair services for aeroderivative gas turbine engine accessories.
Monte Rosa Therapeutics (NASDAQ:GLUE) reported encouraging early clinical results for its molecular glue degrader MRT-2359 in combination with enzalutamide, showing pronounced activity in a genetically defined subset of heavily pretreated metastatic castration-resistant prostate cancer (mCRPC).
Tonix Pharmaceuticals (NASDAQ:TNXP) has secured exclusive worldwide rights to TNX-4900, a selective small-molecule Sigma-1 receptor antagonist positioned as a potential new treatment for chronic neuropathic pain.
Kraft Heinz (NASDAQ:KHC) named Steve Cahillane as its next chief executive officer, tapping the former Kellanova chief to guide the food giant through its planned separation into two independently traded companies.
Corteva (NYSE:CTVA), the agricultural technology giant, and Hexagon Bio, a biotechnology company focused on nature-derived therapeutics, announced a multi-million-dollar joint venture aimed at accelerating the discovery of new crop protection solutions.
Cosette Pharmaceuticals said the U.S. Food and Drug Administration has approved its abbreviated new drug application for the first generic version of CIPRO HC, granting the company 180 days of Competitive Generic Therapy exclusivity and ending a more than 27-year stretch without a generic alternative.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade